Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 7/20 | 0.73 |
| ▸ | GLA | P06280 | 3/20 | 0.50 |
| ▸ | AGL | P35573 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | GBA1 | P04062 | 2/20 | 0.50 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.50 |
| ▸ | FUCA1 | P04066 | 4/20 | 0.48 |
| ▸ | GANC | Q8TET4 | 2/20 | 0.48 |
| ▸ | MAN2A1 | Q16706 | 1/20 | 0.47 |
| ▸ | MAN1B1 | Q9UKM7 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13538449 | 1.00 | MGAM (0.73) | MGAMGLAAGLGAAGBA1 | |
| SCHEMBL19258270 | 1.00 | MGAM (0.73) | MGAMGLAAGLGAAGBA1 | |
| SCHEMBL9789772 | 0.98 | MGAM (0.71) | MGAMGLAAGLGAAGBA1 | |
| Radicamine B SCHEMBL8118948 | 0.85 | MGAM (1.00) | MGAMGLAAGLGAAGBA1 | |
| Radicamine B SCHEMBL2439078 | 0.85 | MGAM (1.00) | MGAMGLAAGLGAAGBA1 | |
| Radicamine B SCHEMBL13848027 | 0.85 | MGAM (1.00) | MGAMGLAAGLGAAGBA1 | |
| SCHEMBL8124155 | 0.83 | MGAM (0.72) | MGAMGLAAGLGAAGBA1 | |
| SCHEMBL8124475 | 0.83 | MGAM (0.72) | MGAMGLAAGLGAAGBA1 | |
| SCHEMBL830731 | 0.83 | MGAM (0.50) | MGAMGAAGBA1MAN2A1MAN1B1 | |
| SCHEMBL830730 | 0.83 | MGAM (0.50) | MGAMGAAGBA1MAN2A1MAN1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170233386-A1 | Compounds Which Have a Protective Activity with Respect to the Action of Toxins and of Viruses with an Intracellular Mode of Action | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-08-17 | — | — | US | disclosed |
| US-20160083355-A1 | COMPOUNDS WHICH HAVE A PROTECTIVE ACTIVITY WITH RESPECT TO THE ACTION OF TOXINS AND OF VIRUSES WITH AN INTRACELLULAR MODE OF ACTION | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083355-A1 | COMPOUNDS WHICH HAVE A PROTECTIVE ACTIVITY WITH RESPECT TO THE ACTION OF TOXINS AND OF VIRUSES WITH AN INTRACELLULAR MODE OF ACTION | HAVCR2, MAVS, ANTXR2 | MGAM 1878/4885GLA 3219/4885AGL 3343/4885 |
| US-20170233386-A1 | Compounds Which Have a Protective Activity with Respect to the Action of Toxins and of Viruses with an Intracellular Mode of Action | HAVCR2, MAVS, ANTXR2 | MGAM 1878/4885GLA 3219/4885AGL 3343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.